₹19,000 Cr Lost to an Evidence Gap - Pharma Webinar

Doctors are turning to AI between two patients. Is your scientific evidence reaching them there? This webinar, held on 14 October 2026 for medical affairs and marketing leaders in pharma, looks at how HCPs in India now find evidence during clinic hours and what that shift means for teams responsible for a novel molecule. Dr Abhishek Charan, Consultant Medical Oncologist at HCG Cancer Centre, Jaipur, opens with the reality of a tier 2 OPD: 50 to 80 patients a day, about five minutes per patient, and AI used between consultations to check biomarkers, treatment eligibility and the latest trials. Vivek Slaria, Founder and CEO of OneRX, then walks through the pharma side: the ₹19,000 crore of guideline backed revenue that stays unrealised every year because evidence does not reach HCPs at the point of care, what oncologists across India are actually asking AI about their line of therapy, where Indian evidence gets overlooked on global AI tools, and how medical affairs teams can take scientific evidence to HCPs at scale within UCPMP guardrails. What you will see How oncologists use AI during clinic hours, not after hours A professor of medical oncology at Tata Memorial Centre, Mumbai, testing OneRX against general purpose AI tools on an Indian breast cancer case PRECISION-AI, India’s first prospective multicentre validation study of a medical AI platform, published in the International Journal of Medical Informatics: 100% clinical safety and 94.7% guideline concordance across three tertiary oncology centres The four gaps for medical affairs: visibility, evidence, reach and measurement Ways to partner: joint CMEs, real world evidence and research, and the AI in Oncology course for HCPs Chapters 09:13 Welcome and introductions, Dr Suchitra, Medical Affairs, OneRX 10:24 Inside a tier 2 OPD: AI between two patients, Dr Abhishek Charan 17:16 Open discussion: what should a medical AI platform look like? 27:21 Why now: ₹19,000 crore and the evidence gap 32:19 Poll: is your evidence reaching doctors on AI? 33:07 The four gaps: visibility, evidence, reach, measurement 34:29 How oncologists across India are prompting OneRX 40:06 Tata Memorial Centre: OneRX tested on an Indian case 43:22 PRECISION-AI validation study results 48:05 Partnering on HCP education within UCPMP guardrails 53:05 Q&A: global AI platforms, doctor trust and medical affairs collaboration 01:07:30 Close About OneRX OneRX is a medical AI platform for evidence summary for clinicians. It is CDSCO registered, clinically validated, and draws only on medical literature, with direct integrations to PubMed, FDA, ClinicalTrials.gov and CDSCO. Real world evidence from India sits higher in the evidence pyramid, so the summary reflects the patient in front of the doctor. The platform is free for doctors. The clinician always decides. For doctors: download OneRX at onerx.ai Read the PRECISION-AI study: https://www.sciencedirect.com/science... For medical affairs teams interested in an HCP education partnership, reach Sanjay Maurya, Business Head, OneRX, on +91 9892180607 or through onerx.ai. #MedicalAffairs #Oncology #HCPEducation #MedicalAI #OneRX #Pharma #UCPMP #IndianPharma #ClinicalEvidence